News

Daily updates from the Miami Breast Cancer Conference begin March 11


 

References

Unable to attend the Miami Breast Cancer Conference? No problem. Oncology Practice will be sending out daily e-mail updates from the conference with summaries of the presentations and video interviews with thought leaders in attendance. Conference presentations will not only cover novel treatment approaches, but also will outline the specifics for applying state-of-the-art treatment strategies to care for patients with breast cancer. Several controversies in the field also will be discussed.

Highly anticipated sessions include: a point/counterpoint on BCT vs. Mastectomy: Is It Time to Stop Giving Patients a Choice?; The Pros and Cons of Contralateral Risk-Reducing Mastectomy; An Immunotherapy Update on Vaccines; and New Developments in Adjuvant Endocrine Therapy in Premenopausal Patients.

View the complete program here and look for multimedia conference coverage to arrive in your e-mail inbox beginning March 11.

Recommended Reading

A Perfect Storm: Tumor biology and genomics
MDedge Hematology and Oncology
Epoetin alfa missed its safety endpoint in metastatic breast cancer
MDedge Hematology and Oncology
Rate of BRCA testing up among young women with breast cancer
MDedge Hematology and Oncology
Cancer death rates show wide geographic variation
MDedge Hematology and Oncology
Breast cancer patients at increased risk of colorectal cancer
MDedge Hematology and Oncology
Making immunotherapy part of routine breast cancer treatment
MDedge Hematology and Oncology
Encouraging data on immunotherapy, cardiotoxicity, and DFS
MDedge Hematology and Oncology
Downturn in reoperation after breast conservation surgery
MDedge Hematology and Oncology
Prevention driving increase in mastectomies
MDedge Hematology and Oncology
Prospective study confirms chemo not needed after low Recurrence Score
MDedge Hematology and Oncology